U.S. markets closed

Pressure BioSciences, Inc. (PBIO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.1800+0.1500 (+7.39%)
At close: 3:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.0300
Open2.0800
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.0000 - 2.1900
52 Week Range0.6000 - 4.4900
Volume77,294
Avg. Volume19,115
Market Cap8.469M
Beta (5Y Monthly)1.07
PE Ratio (TTM)N/A
EPS (TTM)-5.9010
Earnings DateNov 17, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Pressure BioSciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update
    PR Newswire

    Pressure BioSciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

    Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, services, and platform solutions to the worldwide life sciences and other industries, today announced financial results for the third quarter ended September 30, 2020, provided a business update, and offered limited guidance for FY2021.

  • Pressure BioSciences, Inc. to Discuss Third Quarter 2020 Financial Results and Provide Business Update
    PR Newswire

    Pressure BioSciences, Inc. to Discuss Third Quarter 2020 Financial Results and Provide Business Update

    Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2020 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone or via a link on the Company's website) approximately one day after the teleconference.

  • Pressure BioSciences Awarded First U.S. Patent for Revolutionary Ultra Shear Technology Platform
    PR Newswire

    Pressure BioSciences Awarded First U.S. Patent for Revolutionary Ultra Shear Technology Platform

    Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform solutions to the worldwide life sciences and other industries, today announced the award of the first U.S. patent for its revolutionary Ultra Shear Technology™ (UST™) platform entitled "System for High Pressure, High Shear Processing of Fluids." This new patent (US 10,823,159) brings the Company's Intellectual Property ("IP") estate to a total of 26 issued patents.